共 126 条
[1]
Ali S.(2002)Endocrine-responsive breast cancer and strategies for combating resistance Nat. Rev. Cancer 2 101-112
[2]
Coombes R. C.(2006)Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b Cancer Res. 66 7007-7015
[3]
Riggins R. B.(2004)Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway Ann. Oncol. 15 1510-1516
[4]
Thomas K. S.(2003)Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells Endocrinology 144 1032-1044
[5]
Ta H. Q.(2004)Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy Endocr.-Relat. Cancer 11 1-9
[6]
Wen J.(2001)Phosphatidylinositol 3-kinase/Akt-mediated activation of estrogen receptor a, a new model for anti-estrogen resistance J. Biol. Chem. 276 9817-9824
[7]
Davis R. J.(2004)Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells Breast Cancer Res. Treat. 87 167-180
[8]
Schuh N. R.(2002)Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression Clin. Cancer Res. 8 1747-1753
[9]
Donelan S. S.(2001)Phosphatidylinositol-3-OH kinase (P13K)/AKT2, activated in breast cancer, regulates and is induced by Estrogen Receptor (ER) via interaction between ER and PI3K Cancer Res. 61 5985-5991
[10]
Owen K. A.(1994)A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) J. Biol. Chem. 269 5241-5248